IFNG and neoplasm: It has previously been shown that response to checkpoint inhibitor therapy is strongly associated with a high density of tumor-infiltrating lymphocytes (TILs) and an intra-tumoral IFNγ gene signature [31,34,42,43,44], suggesting that endogenous T cell activation is important for eliciting an effective response to checkpoint inhibitors.